Stock listing

Amphastar Pharmaceuticals, Inc.

Selected listing: 29A · DUS · EUR · DE

Amphastar Pharmaceuticals, Inc. (Dusseldorf:29A), Health Technology. Latest release Sep 1, 2026: Amphastar Pharmaceuticals to Present at the Wells Fargo 21st…

29A:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:29A
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference

September 1, 2026

Amphastar Pharmaceuticals : Reports Financial Results for the Three Months Ended June 30, 2026

August 6, 2026

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

July 29, 2026

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

May 26, 2026

Amphastar Pharmaceuticals : Q1 Financial Results (news)

May 8, 2026

All Amphastar Pharmaceuticals, Inc. news →

Events

Replays

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 05:00 PM ET
Watch
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call
Thu, May 07, 2026 · 05:00 PM ET
Watch
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 05:00 PM ET
Watch

Research Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. company profile

View the public company page for Amphastar Pharmaceuticals, Inc. on 6ix.

Amphastar Pharmaceuticals, Inc. news

Read company news and market updates connected to Amphastar Pharmaceuticals, Inc..

Amphastar Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Amphastar Pharmaceuticals, Inc..